These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 8264818

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Tumor markers in the screening, diagnosis and treatment of patients with breast carcinoma].
    van Dalen A.
    Ned Tijdschr Geneeskd; 1994 Jan 08; 138(2):96-7. PubMed ID: 8107911
    [No Abstract] [Full Text] [Related]

  • 3. [Tumor markers in the diagnosis and therapy of intestinal neoplasms].
    Gräter H.
    Schweiz Rundsch Med Prax; 1992 Jul 28; 81(31-32):943-4. PubMed ID: 1496207
    [Abstract] [Full Text] [Related]

  • 4. [Mucoid carcinoma antigen--a new tumor marker].
    Bieglmayer C, Szepesi T, Neunteufel W.
    Gynakol Rundsch; 1988 Jul 28; 28 Suppl 2():203-5. PubMed ID: 3234919
    [No Abstract] [Full Text] [Related]

  • 5. Serum CEA, CA 15-3, and MCA in breast cancer patients: a clinical evaluation.
    Repetto L, Onetto M, Gardin G, Costanzi B, Giudici S, Vitiello E, Merlini L, Naso C, Zannini C, Paganuzzi M.
    Cancer Detect Prev; 1993 Jul 28; 17(3):411-5. PubMed ID: 8402728
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Tumor markers in breast cancer].
    Kurebayashi J.
    Gan To Kagaku Ryoho; 2004 Nov 28; 31(12):2077-81. PubMed ID: 15570944
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Preliminary experience with BCM-IMx as a pretreatment marker of breast tumors].
    Fernández Llana B, Fernández Fernández M, Suárez B, Allende MT.
    Rev Clin Esp; 1992 Mar 28; 190(4):209. PubMed ID: 1589619
    [No Abstract] [Full Text] [Related]

  • 12. The early detection of disseminated (metastasized) breast cancer by serial tumour marker measurements.
    Jäger W.
    Eur J Cancer Prev; 1993 Nov 28; 2 Suppl 3():133-9. PubMed ID: 8298443
    [No Abstract] [Full Text] [Related]

  • 13. Serum CYFRA 21-1 is one of the most reliable tumor markers for breast carcinoma.
    Rodríguez CA, Cruz JJ, Martín T, Gómez A, Olaverri A, Hernández M.
    Cancer; 2002 Aug 01; 95(3):670-1; author reply 671. PubMed ID: 12209762
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical usefulness of CA M26 and CA M29 in breast carcinoma].
    Quaranta M, Micelli G, Coviello M, Donadeo A, Lozupone A, Schittulli F.
    J Nucl Med Allied Sci; 1990 Aug 01; 34(4 Suppl):35-8. PubMed ID: 2092146
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.